← Evidence map

TrialCPT: pharmacometrics & systems pharmacology2025

Concentration-QT modeling demonstrates that the selective mineralocorticoid receptor modulator, balcinrenone (AZD9977), does not prolong QT interval.

Jesper Sundell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 39497618